Results 141 to 150 of about 1,518 (207)

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis. [PDF]

open access: yesAm J Clin Dermatol
Stein Gold L   +8 more
europepmc   +1 more source

Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream. [PDF]

open access: yesJ Eur Acad Dermatol Venereol
Ezzedine K   +5 more
europepmc   +1 more source

998 Ruxolitinib cream significantly modulates inflammatory profiles of atopic dermatitis patients [PDF]

open access: yesJournal of Investigative Dermatology, 2019
S. Owens   +5 more
openaire   +1 more source

097 Novel Genomic Signature Predicts Response to Ruxolitinib Cream in Psoriasis [PDF]

open access: yesJournal of Investigative Dermatology, 2019
H. Liu, M.D. Howell
openaire   +1 more source

Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis

open access: diamond
Vimal H. Prajapati   +12 more
openalex   +2 more sources

157 Ruxolitinib Cream significantly modulates inflammatory profiles of Patients with Vitiligo [PDF]

open access: yesJournal of Investigative Dermatology, 2019
S. Owens   +6 more
openaire   +1 more source

Ruxolitinib Cream Suppresses Th2 Inflammation in Adult Patients With Atopic Dermatitis [PDF]

open access: yesJournal of Allergy and Clinical Immunology, 2019
Sherry Owens, Michael D. Howell
openaire   +1 more source

Home - About - Disclaimer - Privacy